Hyperbaric Oxygen Therapy for Peripheral Neuropathy: Can HBOT Help?

Hyperbaric oxygen therapy for peripheral neuropathy is a question that comes up often among people whose numbness, tingling, or nerve pain hasn't fully responded to standard care, particularly when diabetes is the underlying cause. Peripheral neuropathy, most commonly linked to long-standing diabetes, involves nerve damage that can affect sensation, movement, and circulation in the hands and feet. Hyperbaric oxygen therapy (HBOT), which delivers pressurized oxygen to increase oxygen availability at the tissue level, has a well-established, evidence-based role in certain diabetic wound-healing situations. The evidence for HBOT easing neuropathy nerve symptoms directly, however, is newer, more limited, and tells a different story - one this article lays out clearly, tier by tier.

Understanding Peripheral Neuropathy and Diabetic Nerve Damage

Peripheral neuropathy refers to damage affecting the nerves outside the brain and spinal cord, most often in the feet, legs, and hands. Diabetes is the most common cause, and diabetic peripheral neuropathy is thought to develop from a combination of prolonged high blood sugar, nerve fiber damage, and impaired blood flow to the small vessels that supply the nerves. Common symptoms include numbness, tingling, burning pain, and muscle weakness, which may gradually worsen and increase the risk of unnoticed injuries, particularly on the feet.

Because reduced microvascular circulation appears to play a role in both nerve damage and slow-healing wounds in people with diabetes, researchers have looked at whether therapies that increase tissue oxygen delivery, including HBOT, might support either or both of these related problems. As the sections below explain, the evidence for these two outcomes - wound healing and nerve-symptom relief - is not the same, and the two shouldn't be treated interchangeably.

What Is Hyperbaric Oxygen Therapy and How Does It Work?

Hyperbaric oxygen therapy involves breathing near-100% oxygen inside a pressurized chamber, which increases the amount of oxygen dissolved directly in blood plasma and appears to allow more oxygen to reach tissue that would otherwise be poorly supplied by damaged or narrowed blood vessels. This increased oxygen availability is thought to help reduce inflammation and support the body's own cellular repair processes.

At a mechanistic level, HBOT has been shown to mobilize bone-marrow-derived stem and progenitor cells - one study found an approximately eightfold increase in circulating CD34+ progenitor cells after a full course of treatments, through a nitric-oxide-dependent pathway (Thom et al., American Journal of Physiology-Heart and Circulatory Physiology, 2006). This kind of mechanistic research helps explain why HBOT is biologically plausible as a tissue-repair-supporting therapy, though a plausible mechanism is not the same as proof of clinical benefit for any specific condition - that requires evidence from clinical trials, discussed in the next two sections.

How a Typical HBOT Session Works

During a session, a patient rests inside a hyperbaric chamber while trained clinical staff monitor pressure and oxygen delivery throughout. Protocols vary by clinic and by the condition being addressed. At Humanaut Health, HBOT sessions are delivered by trained clinical staff as part of a broader, individualized care plan, an approach that reflects the same personalized model used across Humanaut's regenerative medicine approaches like stem cell therapy.

The Evidence for HBOT and Diabetic Foot Ulcers: Where the Research Is Strongest

Of the two questions this article addresses, HBOT's evidence base is most established in the context of diabetic foot ulcers, chronic, slow-healing wounds that are a serious complication of diabetic peripheral neuropathy and poor circulation. This is also the context in which HBOT is most closely tied to an FDA-cleared use: hyperbaric oxygen is cleared for the "enhancement of healing in selected problem wounds," a category that includes certain diabetic wounds of the lower extremity meeting specific severity and duration criteria.

Even within this stronger evidence tier, results are mixed rather than uniformly positive, and hedged language matters. A Cochrane systematic review found that HBOT was associated with improved diabetic foot ulcer healing at six weeks, but this benefit was not sustained at twelve months, and the review did not find a reduction in major amputation rates; the authors also flagged limitations in the design and reporting of many included trials (Kranke et al., Cochrane Database of Systematic Reviews, 2015). A separate 2021 systematic review and meta-analysis reported that HBOT was associated with significantly improved complete wound healing and a reduced rate of major amputation compared with standard care alone, though it did not show a benefit for minor amputation (Sharma et al., Scientific Reports, 2021). An earlier randomized, double-blind, placebo-controlled trial similarly found that adjunctive HBOT facilitated healing of chronic diabetic foot ulcers in selected patients at one year (Löndahl et al., Diabetes Care, 2010).

Other well-designed trials have not found the same benefit. A double-blind, sham-controlled randomized trial found that HBOT did not reduce indications for amputation in patients with nonhealing diabetic lower-limb ulcers (Fedorko et al., Diabetes Care, 2016), and the largest randomized trial to date of HBOT in diabetic ischemic lower-extremity ulcers found that adding HBOT to standard care did not significantly improve complete wound healing or limb salvage (Santema et al., Diabetes Care, 2018). Taken together, this body of evidence suggests HBOT may offer a benefit for some patients with diabetic foot ulcers under the right clinical circumstances, but it is not a guaranteed or universal outcome.

Hyperbaric Oxygen Therapy for Diabetic Neuropathy: What the Evidence on Nerve Symptoms Shows

A separate, and less-established, question is whether HBOT can directly ease neuropathy symptoms, such as numbness, tingling, pain, or reduced sensation, rather than help heal an associated wound. This is an important distinction: general peripheral and diabetic neuropathy symptom relief is not an FDA-cleared indication for hyperbaric oxygen therapy, and the supporting hbot neuropathy research, while suggestive, is at an earlier and more preliminary stage than the wound-healing evidence discussed above.

A 2024 systematic review and meta-analysis of 14 randomized controlled trials, involving 675 patients treated with HBOT and 648 treated with standard therapy alone, found that HBOT was associated with a higher "effective treatment rate" and improvements in motor and sensory nerve conduction velocity across several major nerves, with few adverse events reported (Weng et al., Medicine, 2024). This is currently the strongest evidence specific to nerve-symptom outcomes, though the authors noted variability among the included trials, and evidence at this level is generally considered moderate rather than high confidence.

A smaller randomized trial of 42 patients found that ten HBOT sessions added to standard care were associated with improved sensory and motor nerve conduction and better neuropathy questionnaire scores after two weeks, compared with standard care alone (Elshinnawy et al., International Journal of Pharmaceutical Research, 2021). Given its small sample size and short follow-up period, this finding should be considered preliminary and exploratory rather than conclusive.

Taken together, current hbot neuropathy research suggests HBOT may be associated with measurable, short-term improvements in nerve conduction for some patients, but this evidence is still developing, has not translated into an FDA-cleared indication, and should not be understood as an established or guaranteed treatment for neuropathy symptoms on its own.

What Do Medical Guidelines Say About HBOT for Diabetic Wounds and Neuropathy?

The International Working Group on the Diabetic Foot's 2023 guideline update offers a conditional recommendation to consider HBOT as an adjunct therapy for neuro-ischemic or ischemic diabetes-related foot ulcers when standard wound care alone has not been sufficient, while also noting that this recommendation is based on low-certainty evidence (Chen et al., Diabetes/Metabolism Research and Reviews, 2024). Notably, this guideline addresses wound care specifically. No comparable major clinical practice guideline currently offers a similar recommendation for using HBOT to treat generalized peripheral neuropathy symptoms in the absence of a wound.

How Does HBOT Compare With Other Approaches to Neuropathy?

For most people with diabetic peripheral neuropathy, standard medical management remains the foundation of care: consistent blood sugar control, medications for nerve pain, physical therapy, and regular foot care and monitoring to catch wound risk early. Within that framework, HBOT is best understood as a potential adjunct considered under physician guidance for specific situations, particularly wound-related ones, rather than a replacement for established care.

Because circulatory and metabolic factors play a role in both nerve health and wound risk, some clinicians and patients also look to comprehensive diagnostics like an advanced health check to better understand individual risk factors before considering additional interventions. Any decision about adding HBOT to a neuropathy or wound-care plan should involve an individualized conversation with a qualified healthcare provider.

Is Hyperbaric Oxygen Therapy Safe? Risks and Side Effects

HBOT generally has a favorable safety profile when administered appropriately. The most common adverse event is middle ear barotrauma, related to pressure changes during treatment; temporary changes in vision (myopia) and claustrophobia have also been reported. Serious complications, such as seizure or pulmonary oxygen toxicity, are considered rare (Heyboer et al., Advances in Wound Care, 2017). Because candidacy depends on individual health history, a qualified clinician should evaluate any person's specific situation, including conditions that may affect suitability for treatment, before HBOT begins.

What to Expect: Sessions, Timeline, and Realistic Outcomes

Session protocols in the studies discussed above varied by condition and research design, and real-world treatment plans are similarly individualized rather than one-size-fits-all. At Humanaut Health, HBOT is delivered by trained clinical staff as part of a personalized care plan, with candidacy and session planning determined on an individual basis.

It's worth setting realistic expectations: even within the stronger wound-healing evidence base, results vary across studies and patients, and HBOT is not described in the research as a guaranteed fix. For neuropathy symptoms specifically, current evidence suggests possible short-term improvement for some patients, not a dependable or universal outcome. Anyone considering HBOT for either use should discuss individual goals and expectations directly with a treating clinician.

Frequently Asked Questions

Does hyperbaric oxygen therapy for peripheral neuropathy actually work?

Some research suggests HBOT may be associated with improvements in nerve conduction and symptom scores in diabetic peripheral neuropathy, but this evidence is still developing, and general peripheral neuropathy is not an FDA-cleared indication for HBOT.

Is hyperbaric oxygen therapy for diabetic neuropathy FDA-approved?

No. HBOT is FDA-cleared for a specific set of indications, including the enhancement of healing in certain diabetic wounds of the lower extremity, but general diabetic neuropathy symptom relief is not among the FDA-cleared indications.

How does HBOT work for nerve-related symptoms?

HBOT increases the amount of oxygen dissolved in blood plasma, which is thought to improve oxygen delivery to poorly circulated tissue, reduce inflammation, and support the body's natural repair processes, including a proposed role in mobilizing stem and progenitor cells.

How many HBOT sessions might be needed?

Session counts vary across the studies discussed in this article and depend on the condition being treated, so any specific protocol should be determined individually with a physician rather than based on a fixed general number.

Is hbot neuropathy treatment covered by insurance?

Insurance coverage for HBOT is generally tied to its FDA-cleared indications, such as certain diabetic wounds, rather than to generalized neuropathy symptom treatment; patients should verify coverage details directly with their insurance plan.

What are the risks or side effects of hyperbaric oxygen therapy?

The most commonly reported side effect is middle ear barotrauma; temporary vision changes and claustrophobia have also been reported, while serious events like seizure or pulmonary oxygen toxicity are rare.

Can HBOT help diabetic foot ulcers as well as nerve pain?

The evidence for HBOT and diabetic foot ulcer healing is more established, including a role in an FDA-cleared wound-care pathway, while evidence for direct nerve-symptom relief is more preliminary; the two should be evaluated as separate questions.

Who might not be a good candidate for HBOT?

Candidacy depends on individual medical history and should always be determined through evaluation by a qualified clinician; this article is informational only and not a substitute for that individualized medical assessment.

Key Takeaways

• Peripheral neuropathy, especially diabetic neuropathy, involves nerve damage and circulatory changes that affect sensation and, in some cases, wound healing.
• Hyperbaric oxygen therapy for peripheral neuropathy has its strongest evidence in the diabetic-wound-healing context, which includes an FDA-cleared pathway for select problem wounds, though results are mixed, not guaranteed.
• Evidence that HBOT directly improves neuropathy nerve symptoms is more preliminary, and general peripheral neuropathy is not currently an FDA-cleared HBOT indication.
• HBOT has a generally favorable safety profile, though it is not risk-free, and candidacy should be assessed individually.
• Anyone exploring HBOT for neuropathy or related wound concerns should do so as part of an individualized plan developed with a qualified clinician.

Talk to Humanaut Health About HBOT

If you're exploring hyperbaric oxygen therapy as part of a broader care plan, learn more about Humanaut Health's HBOT program and speak with the clinical team about candidacy.